PSK12 PATIENT REPORTED OUTCOMES IN PSORIASIS

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Patient-Reported Outcomes, Patient-Reported Information

Internet communication is developing. Social networking sites enable patients to publish and receive communications very easily. Many stakeholders, including patients, are using these media to find new ways to make sense of diseases, to find and discuss treatments, and to give support to patients and their caregivers. We argue for a new definition of patient-reported information (PRI), which di...

متن کامل

Patient-reported Outcomes

Key points Many gastrointestinal diseases are symptomdriven, so the patient’s perspective is particularly important in this area. Patient-reported outcomes (PROs) provide essential information that objective measures and clinician assessment may fail to capture. PROs can be measured in a scientific, reliable, and valid manner. Generic, disease-specific and treatmentspecific PRO instruments exis...

متن کامل

Patient-reported outcomes in schizophrenia.

BACKGROUND Patient-reported outcomes are increasingly used to evaluate the care of people with schizophrenia. AIMS To review established and emerging patient-reported outcomes in schizophrenia research, assessmenttools and key findings. METHOD A non-systematic review addressing relevant constructs, the associated scales and key empirical findings. RESULTS Patient-reported outcomes in schi...

متن کامل

Patient-reported outcomes in psychiatry

The recent trend for recognizing the need that patients actively participate in the assessment of the outcome of treatment is a welcome development, not only because it adds valuable data, but also because its recognition of the partnership role that the patients should have in research on outcome of mental illness.

متن کامل

Validity and reliability of patient reported outcomes used in Psoriasis: results from two randomized clinical trials

BACKGROUND Two Phase III randomized controlled clinical trials were conducted to assess the efficacy, safety, and tolerability of weekly subcutaneous administration of efalizumab for the treatment of psoriasis. Patient reported measures of psoriasis-related functionality and health-related quality of life and of psoriasis-related symptom assessments were included as part of the trials. OBJECT...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Value in Health

سال: 2007

ISSN: 1098-3015

DOI: 10.1016/s1098-3015(10)65618-5